Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis

Aaron P. Russell, Shogo Wada, Lodovica Vergani, M. Benjamin Hock, Séverine Lamon, Bertrand Léger, Takashi Ushida, Romain Cartoni, Glenn D. Wadley, Peter Hespel, Anastasia Kralli, Gianni Soraru, Corrado Angelini, Takayuki Akimoto

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Skeletal muscle mitochondrial dysfunction is believed to play a role in the progression and severity of amyotrophic lateral sclerosis (ALS). The regulation of transcriptional co-activators involved in mitochondrial biogenesis and function in ALS is not well known. When compared with healthy control subjects, patients with ALS, but not neurogenic disease (ND), had lower levels of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) mRNA and protein and estrogen-related receptor-α (ERRα) and mitofusin-2 (Mfn2) mRNA. PGC-1β, nuclear respiratory factor-1 (NRF-1) and Mfn1 mRNA as well as cytochrome C oxidase subunit IV (COXIV) mRNA and protein were lower in patients with ALS and ND. Both patient groups had reductions in citrate synthase and cytochrome c oxidase activity. Similar observations were made in skeletal muscle from transgenic ALS G93A transgenic mice. In vitro, PGC-1α and PGC-1β regulated Mfn1 and Mfn2 in an ERRα-dependent manner. Compared to healthy controls, miRNA 23a, 29b, 206 and 455 were increased in skeletal muscle of ALS patients. miR-23a repressed PGC-1α translation in a 3' UTR dependent manner. Transgenic mice over expressing miR-23a had a reduction in PGC-1α, cytochome-b and COXIV protein levels. These results show that skeletal muscle mitochondrial dysfunction in ALS patients is associated with a reduction in PGC-1α signalling networks involved in mitochondrial biogenesis and function, as well as increases in several miRNAs potentially implicated in skeletal muscle and neuromuscular junction regeneration. As miR-23a negatively regulates PGC-1α signalling, therapeutic inhibition of miR-23a may be a strategy to rescue PGC-1α activity and ameliorate skeletal muscle mitochondrial function in ALS.

Original languageEnglish
Pages (from-to)107-117
Number of pages11
JournalNeurobiology of Disease
Volume49
Issue number1
DOIs
Publication statusPublished - 2013 Jan
Externally publishedYes

Fingerprint

Mitochondrial Genes
Amyotrophic Lateral Sclerosis
MicroRNAs
Skeletal Muscle
Messenger RNA
Organelle Biogenesis
Electron Transport Complex IV
Transgenic Mice
Nuclear Respiratory Factor 1
Citrate (si)-Synthase
Peroxisome Proliferator-Activated Receptors
Neuromuscular Junction
Protein Subunits
3' Untranslated Regions
Estrogen Receptors
Regeneration
Healthy Volunteers
Oxidoreductases

Keywords

  • ALS (amyotrophic lateral sclerosis)
  • MicroRNA
  • Mitofusin
  • Peroxiome proliferator activator receptor γ co-activator-1
  • Skeletal muscle

ASJC Scopus subject areas

  • Neurology
  • Medicine(all)

Cite this

Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. / Russell, Aaron P.; Wada, Shogo; Vergani, Lodovica; Hock, M. Benjamin; Lamon, Séverine; Léger, Bertrand; Ushida, Takashi; Cartoni, Romain; Wadley, Glenn D.; Hespel, Peter; Kralli, Anastasia; Soraru, Gianni; Angelini, Corrado; Akimoto, Takayuki.

In: Neurobiology of Disease, Vol. 49, No. 1, 01.2013, p. 107-117.

Research output: Contribution to journalArticle

Russell, AP, Wada, S, Vergani, L, Hock, MB, Lamon, S, Léger, B, Ushida, T, Cartoni, R, Wadley, GD, Hespel, P, Kralli, A, Soraru, G, Angelini, C & Akimoto, T 2013, 'Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis', Neurobiology of Disease, vol. 49, no. 1, pp. 107-117. https://doi.org/10.1016/j.nbd.2012.08.015
Russell, Aaron P. ; Wada, Shogo ; Vergani, Lodovica ; Hock, M. Benjamin ; Lamon, Séverine ; Léger, Bertrand ; Ushida, Takashi ; Cartoni, Romain ; Wadley, Glenn D. ; Hespel, Peter ; Kralli, Anastasia ; Soraru, Gianni ; Angelini, Corrado ; Akimoto, Takayuki. / Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. In: Neurobiology of Disease. 2013 ; Vol. 49, No. 1. pp. 107-117.
@article{b5b1ca828dd84624b4861705fc52ea37,
title = "Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis",
abstract = "Skeletal muscle mitochondrial dysfunction is believed to play a role in the progression and severity of amyotrophic lateral sclerosis (ALS). The regulation of transcriptional co-activators involved in mitochondrial biogenesis and function in ALS is not well known. When compared with healthy control subjects, patients with ALS, but not neurogenic disease (ND), had lower levels of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) mRNA and protein and estrogen-related receptor-α (ERRα) and mitofusin-2 (Mfn2) mRNA. PGC-1β, nuclear respiratory factor-1 (NRF-1) and Mfn1 mRNA as well as cytochrome C oxidase subunit IV (COXIV) mRNA and protein were lower in patients with ALS and ND. Both patient groups had reductions in citrate synthase and cytochrome c oxidase activity. Similar observations were made in skeletal muscle from transgenic ALS G93A transgenic mice. In vitro, PGC-1α and PGC-1β regulated Mfn1 and Mfn2 in an ERRα-dependent manner. Compared to healthy controls, miRNA 23a, 29b, 206 and 455 were increased in skeletal muscle of ALS patients. miR-23a repressed PGC-1α translation in a 3' UTR dependent manner. Transgenic mice over expressing miR-23a had a reduction in PGC-1α, cytochome-b and COXIV protein levels. These results show that skeletal muscle mitochondrial dysfunction in ALS patients is associated with a reduction in PGC-1α signalling networks involved in mitochondrial biogenesis and function, as well as increases in several miRNAs potentially implicated in skeletal muscle and neuromuscular junction regeneration. As miR-23a negatively regulates PGC-1α signalling, therapeutic inhibition of miR-23a may be a strategy to rescue PGC-1α activity and ameliorate skeletal muscle mitochondrial function in ALS.",
keywords = "ALS (amyotrophic lateral sclerosis), MicroRNA, Mitofusin, Peroxiome proliferator activator receptor γ co-activator-1, Skeletal muscle",
author = "Russell, {Aaron P.} and Shogo Wada and Lodovica Vergani and Hock, {M. Benjamin} and S{\'e}verine Lamon and Bertrand L{\'e}ger and Takashi Ushida and Romain Cartoni and Wadley, {Glenn D.} and Peter Hespel and Anastasia Kralli and Gianni Soraru and Corrado Angelini and Takayuki Akimoto",
year = "2013",
month = "1",
doi = "10.1016/j.nbd.2012.08.015",
language = "English",
volume = "49",
pages = "107--117",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis

AU - Russell, Aaron P.

AU - Wada, Shogo

AU - Vergani, Lodovica

AU - Hock, M. Benjamin

AU - Lamon, Séverine

AU - Léger, Bertrand

AU - Ushida, Takashi

AU - Cartoni, Romain

AU - Wadley, Glenn D.

AU - Hespel, Peter

AU - Kralli, Anastasia

AU - Soraru, Gianni

AU - Angelini, Corrado

AU - Akimoto, Takayuki

PY - 2013/1

Y1 - 2013/1

N2 - Skeletal muscle mitochondrial dysfunction is believed to play a role in the progression and severity of amyotrophic lateral sclerosis (ALS). The regulation of transcriptional co-activators involved in mitochondrial biogenesis and function in ALS is not well known. When compared with healthy control subjects, patients with ALS, but not neurogenic disease (ND), had lower levels of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) mRNA and protein and estrogen-related receptor-α (ERRα) and mitofusin-2 (Mfn2) mRNA. PGC-1β, nuclear respiratory factor-1 (NRF-1) and Mfn1 mRNA as well as cytochrome C oxidase subunit IV (COXIV) mRNA and protein were lower in patients with ALS and ND. Both patient groups had reductions in citrate synthase and cytochrome c oxidase activity. Similar observations were made in skeletal muscle from transgenic ALS G93A transgenic mice. In vitro, PGC-1α and PGC-1β regulated Mfn1 and Mfn2 in an ERRα-dependent manner. Compared to healthy controls, miRNA 23a, 29b, 206 and 455 were increased in skeletal muscle of ALS patients. miR-23a repressed PGC-1α translation in a 3' UTR dependent manner. Transgenic mice over expressing miR-23a had a reduction in PGC-1α, cytochome-b and COXIV protein levels. These results show that skeletal muscle mitochondrial dysfunction in ALS patients is associated with a reduction in PGC-1α signalling networks involved in mitochondrial biogenesis and function, as well as increases in several miRNAs potentially implicated in skeletal muscle and neuromuscular junction regeneration. As miR-23a negatively regulates PGC-1α signalling, therapeutic inhibition of miR-23a may be a strategy to rescue PGC-1α activity and ameliorate skeletal muscle mitochondrial function in ALS.

AB - Skeletal muscle mitochondrial dysfunction is believed to play a role in the progression and severity of amyotrophic lateral sclerosis (ALS). The regulation of transcriptional co-activators involved in mitochondrial biogenesis and function in ALS is not well known. When compared with healthy control subjects, patients with ALS, but not neurogenic disease (ND), had lower levels of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) mRNA and protein and estrogen-related receptor-α (ERRα) and mitofusin-2 (Mfn2) mRNA. PGC-1β, nuclear respiratory factor-1 (NRF-1) and Mfn1 mRNA as well as cytochrome C oxidase subunit IV (COXIV) mRNA and protein were lower in patients with ALS and ND. Both patient groups had reductions in citrate synthase and cytochrome c oxidase activity. Similar observations were made in skeletal muscle from transgenic ALS G93A transgenic mice. In vitro, PGC-1α and PGC-1β regulated Mfn1 and Mfn2 in an ERRα-dependent manner. Compared to healthy controls, miRNA 23a, 29b, 206 and 455 were increased in skeletal muscle of ALS patients. miR-23a repressed PGC-1α translation in a 3' UTR dependent manner. Transgenic mice over expressing miR-23a had a reduction in PGC-1α, cytochome-b and COXIV protein levels. These results show that skeletal muscle mitochondrial dysfunction in ALS patients is associated with a reduction in PGC-1α signalling networks involved in mitochondrial biogenesis and function, as well as increases in several miRNAs potentially implicated in skeletal muscle and neuromuscular junction regeneration. As miR-23a negatively regulates PGC-1α signalling, therapeutic inhibition of miR-23a may be a strategy to rescue PGC-1α activity and ameliorate skeletal muscle mitochondrial function in ALS.

KW - ALS (amyotrophic lateral sclerosis)

KW - MicroRNA

KW - Mitofusin

KW - Peroxiome proliferator activator receptor γ co-activator-1

KW - Skeletal muscle

UR - http://www.scopus.com/inward/record.url?scp=84866491615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866491615&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2012.08.015

DO - 10.1016/j.nbd.2012.08.015

M3 - Article

VL - 49

SP - 107

EP - 117

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 1

ER -